Sadhana Nitro Chem Confirms Rights Issue Funds Used as Planned

CHEMICALS
Whalesbook Corporate News Logo
AuthorAarav Shah|Published at:
Sadhana Nitro Chem Confirms Rights Issue Funds Used as Planned
Overview

Sadhana Nitro Chem submitted its first Monitoring Agency Report for the quarter ending March 31, 2026. Prepared by Acuite Ratings and Research, the report confirms the company used ₹251.95 Cr of its ₹263.53 Cr Rights Issue funds as planned, primarily for its new manufacturing facility and working capital. This adherence provides investors financial assurance.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Sadhana Nitro Chem: Funds Used as Planned

Reader Takeaway: Funds used as planned for new facility; ₹11.58 Cr balance for ongoing working capital needs.

Filing Details

Sadhana Nitro Chem Limited has filed its first Monitoring Agency Report for the quarter ending March 31, 2026. Acuite Ratings and Research Limited prepared the report, confirming that the funds raised through its Rights Issue have been used in line with the company's stated objectives. A total of ₹251.95 crore has been deployed, with ₹11.58 crore remaining unutilized.

Why This Matters to Investors

This filing provides important financial assurance to investors. It shows that the company's capital expenditure plans and operational expansion are progressing as communicated when the Rights Issue was launched. Following fund utilization commitments demonstrates financial discipline.

Rights Issue Background

Sadhana Nitro Chem launched a Rights Issue totaling ₹263.53 crore. The main goal of this fundraising was to build a new greenfield manufacturing facility for Nitrocellulose and related ancillaries. Part of the funds was also set aside to strengthen the company's working capital.

Key Takeaways

  • Investors have confirmation that their capital is being deployed according to the company's strategic plans.
  • The company shows financial discipline and commitment to executing its projects.
  • The path for using the remaining funds for working capital is clear.

Potential Risks

  • While fund utilization is confirmed, timely and efficient deployment of the remaining ₹11.58 crore for working capital remains important.
  • Any delays in bringing the new manufacturing facility online could pose a risk.

Industry Landscape

Sadhana Nitro Chem operates within the specialty chemicals sector. Key players such as Navin Fluorine International Ltd and Clean Science and Technology Ltd are active in this area, though with different product focuses. These competitors highlight the competitive and dynamic nature of India's specialty chemicals market.

Key Figures

  • Rights Issue Size: ₹263.53 Cr
  • Funds Utilized: ₹251.95 Cr as of March 31, 2026 (Q4 FY26)
  • Unutilized Funds: ₹11.58 Cr as of March 31, 2026 (Q4 FY26)

What to Watch Next

  • The company's progress in utilizing the remaining ₹11.58 crore within the next 30-45 days.
  • Updates on the new Nitrocellulose manufacturing facility's commissioning and production ramp-up.
  • The company's ongoing financial performance and operational efficiency following the facility expansion.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.